What is the evidence for Tirzepatide?
Tirzepatide is an approved dual-receptor medicine with a mature human evidence base; it is not interchangeable with investigational retatrutide.
DIRECT ANSWER
Tirzepatide evidence summary.
Tirzepatide is an approved dual-receptor medicine with a mature human evidence base; it is not interchangeable with investigational retatrutide.
Reviewed August 7, 2026. Each statement links to its evidence record, followed by the primary and official sources used for this answer.
Randomized trials and approved labeling support defined metabolic and sleep-apnea indications.
Open evidence recordDual GIP/GLP-1 pharmacology is well characterized; approved-use evidence is clinical.
Open evidence recordApproval and evidence attach to labeled products, not to every product marketed with the ingredient name.
Open evidence recordPRIMARY & OFFICIAL SOURCES
Sources for this answer.
2 source records, with duplicates removed.